Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Biohaven Pharmaceutical Holding Company

Tracked across 3 events · 18 articles · First seen Jul 25, 2025 · Last active Sep 09, 2025

Sentiment
-60
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 -70
Business
Impact: Biohaven Pharmaceutical Holding Company is facing a federal securities class action lawsuit for allegedly making false and misleading statements regarding its drug candidates, troriluzole and BHV-7000. Its stock price fell significantly after the FDA extended the PDUFA date for troriluzole.
Jul 25, 2025 · 6 articles
4 -70
Regulatory
Impact: Biohaven Pharmaceutical Holding Company is the target of a class action lawsuit due to alleged false statements and concealment regarding its product candidates, troriluzole and BHV-7000, which negatively impacted its business and financial condition.
Jul 25, 2025 · 6 articles
2 -40
Business
Impact: Biohaven Pharmaceutical Holding Company is the defendant in a securities class action lawsuit, accused of making false and misleading statements regarding its drug prospects.
Aug 15, 2025 · 6 articles
ERGEN INTELLIGENCE
Track Biohaven Pharmaceutical Holding Company live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.